Author: bobby
Targeted Protein Degradation: PROTACs, Molecular Glues, and the Future of Drugging Undruggable Targets
Targeted protein degradation is reshaping how researchers approach previously “undruggable” targets and offering a fresh toolkit for drug discovery. Rather than blocking a protein’s active site, degradation strategies remove the problematic protein from the cell, producing catalytic effects and opening therapeutic options across oncology, neurodegeneration, inflammation, and infectious disease. How targeted degradation worksTwo main modalities…
Read More
Regulatory Affairs: How to Accelerate Approvals with Risk‑Based Strategies, Real‑World Evidence, and eCTD
Regulatory Affairs: Practical Strategies for a Faster, Safer Path to Market Regulatory Affairs professionals are at the intersection of science, law, and patient safety. With regulators emphasizing agility and data quality, building a practical, risk-based regulatory strategy is essential for timely approvals and sustained market access. Where to focus first– Regulatory intelligence: Map requirements across…
Read More
7 Pharmaceutical Technology Trends Reshaping Drug Development: Continuous Manufacturing, PAT, 3D Printing & Sustainability
Modern pharmaceutical technology is reshaping how medicines are designed, manufactured, and delivered. Innovations focus on faster development cycles, more flexible production, improved product quality, and reduced environmental impact. Several key trends are defining the field and offering actionable opportunities for manufacturers, contract developers, and regulators. Continuous manufacturing and Process Analytical Technology (PAT)Moving away from traditional…
Read More
Continuous Manufacturing in Pharma: Benefits, Tech, and Implementation Guide
Continuous manufacturing is reshaping how medicines are developed, produced, and delivered. Compared with traditional batch processing, continuous approaches streamline operations, tighten quality control, and enable faster responses to demand. For pharmaceutical manufacturers aiming to stay competitive, understanding the practical benefits and challenges of continuous production is essential. Why continuous manufacturing matters– Greater efficiency: Continuous lines…
Read More
Targeted Protein Degradation (PROTACs): A Practical Guide to Strategies, Challenges, and Therapeutic Opportunities
Targeted protein degradation is reshaping the landscape of drug discovery by offering a fundamentally different way to control disease biology. Instead of blocking a protein’s activity with traditional inhibitors, degradation strategies remove the protein from the cell, opening therapeutic possibilities for targets previously considered “undruggable.” How targeted protein degradation worksSmall molecules called degraders recruit an…
Read More
Biotech Startups: Practical Playbook to De‑risk Programs, Accelerate Growth, and Attract Investors
Biotech Startups: Practical Playbook for Growth and De‑risking Biotech startups sit at the intersection of science, regulation, and capital. Success depends on more than a promising molecule — it requires a repeatable plan to de‑risk programs, attract partners and investors, and navigate complex manufacturing and regulatory pathways. Below are focused strategies that founders and investors…
Read More
Post-Market Surveillance (PMS) Best Practices for Regulatory Affairs Teams: Compliance, RWE & Technology
Regulatory affairs teams face growing pressure to demonstrate that products remain safe and effective throughout their lifecycle. Post-market surveillance (PMS) is no longer a passive checklist item; it’s a strategic requirement that protects patients, preserves market access, and reduces business risk. Understanding practical, compliance-driven PMS practices helps regulatory teams stay ahead of inspections and evolving…
Read More
Personalized Medicine Explained: Genomic Testing, Pharmacogenomics & Digital Health
Personalized medicine is reshaping how clinicians prevent, diagnose, and treat disease by tailoring care to an individual’s biology, lifestyle, and environment. Rather than relying on a one-size-fits-all approach, personalized or precision medicine uses genetic information, biomarkers, and patient-specific data to guide decisions that improve outcomes and reduce unwanted side effects. How it worksAt the core…
Read More
Next-Generation Drug Discovery: Functional Genomics, AI-Powered Design, and Translational Models
Drug discovery is moving beyond incremental improvement toward more integrated, biology-driven strategies that shorten timelines and improve success rates. Breakthroughs in experimental biology, advanced computation, and translational models are reshaping how targets are chosen, molecules are optimized, and candidates are tested before entering human studies. Target identification now leans heavily on functional genomics and single-cell…
Read More
How to Build Regulatory-Ready Real-World Evidence for Drug and Device Submissions
Real-world evidence (RWE) is reshaping regulatory strategy across drug and device lifecycles. Regulators are increasingly receptive to RWE when it’s reliable, transparent, and fit for purpose — not as a replacement for randomized trials but as a complementary source that can speed decision-making, improve safety monitoring, and support label expansions. For regulatory affairs teams, integrating…
Read More